AdvanDx Inc, Woburn, Mass, now offers the Gram-Negative QuickFISH BC, a rapid molecular diagnostic test that identifies bloodstream infections caused by Escherichia coli, and/or Pseudomonas aeruginosa, and/or Klebsiella pneumoniae within 20 minutes of a positive blood culture.
The new assay expands the QuickFISH Platform, which can now ID pathogens responsible for 90% of positive blood cultures.
Two gram-positive QuickFISH tests are already on the market; Staphylococcus QuickFISH BC for the identification of Staphylococcus aureus and/or coagulase-negative staphylococci; and Enterococcus QuickFISH BC, for the identification of Enterococcus faecalis and/or selected other enterococci.
The company plans to introduce its fourth QuickFISH assay for identification of Candida species from positive blood cultures in the second half of 2013, following regulatory clearance.
[Source: AdvanDx]
